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Abstract
The lumen of endosomal organelles becomes increasingly acidic when going from the cell surface to lysosomes. Luminal pH
thereby regulates important processes such as the release of internalized ligands from their receptor or the activation of
lysosomal enzymes. The main player in endosomal acidification is the vacuolar ATPase (V-ATPase), a multi-subunit
transmembrane complex that pumps protons from the cytoplasm to the lumen of organelles, or to the outside of the cell.
The active V-ATPase is composed of two multi-subunit domains, the transmembrane V0 and the cytoplasmic V1. Here we
found that the ratio of membrane associated V1/Vo varies along the endocytic pathway, the relative abundance of V1 being
higher on late endosomes than on early endosomes, providing an explanation for the higher acidity of late endosomes. We
also found that all membrane-bound V-ATPase subunits were associated with detergent resistant membranes (DRM)
isolated from late endosomes, raising the possibility that association with lipid-raft like domains also plays a role in
regulating the activity of the proton pump. In support of this, we found that treatment of cells with U18666A, a drug that
leads to the accumulation of cholesterol in late endosomes, affected acidification of late endosome. Altogether our findings
indicate that the activity of the vATPase in the endocytic pathway is regulated both by reversible association/dissociation
and the interaction with specific lipid environments.
Citation: Lafourcade C, Sobo K, Kieffer-Jaquinod S, Garin J, van der Goot FG (2008) Regulation of the V-ATPase along the Endocytic Pathway Occurs through
Reversible Subunit Association and Membrane Localization. PLoS ONE 3(7): e2758. doi:10.1371/journal.pone.0002758
Editor: Etienne Joly, Universite´ de Toulouse, France
Received April 11, 2008; Accepted June 20, 2008; Published July 23, 2008
Copyright:  2008 Lafourcade et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Swiss National Science foundation and from a grant from Novartis Consumer Health Foundation to
G.v.d.G. C.L is a recipient of a Roche Research Foundation post-doctoral fellowship. G.v.d.G is an international Fellow of the Howard Hughes Medical Institute.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gisou.vandergoot@epfl.ch
Introduction
During evolution, compartmentalization of the intracellular
space has allowed to spatially restrict and optimize certain
biochemical reactions and pathways. Therefore the lumens of
different organelles have different properties in terms of ion
concentrations, redox states and also pH. Organellar pH is tightly
regulated ranging from neutral in the endoplasmic reticulum, to
mildly acidic in early endosomes and highly acidic in late
endosomes/lysosomes [1]. Acidic pH affects a number of
biological events such as membrane trafficking, dissociation of
ligand-receptor complexes after internalization and activation of
lysosomal enzymes [1]. Although pH regulation can be modulated
by a variety of factors such as proton leak, ClC chloride channels
or Na,K-ATPases [2,3,4,5], it is primarily determined by the
activity of the vacuolar ATPase (V-ATPase), which is expressed in
all eukaryotes from yeast to mammals [6,7].
The V-ATPase is a multi-subunit complex composed of two
domains, a peripheral V1 domain containing the ATPase activity and
a membrane bound V0 domain responsible for translocation of
protons across the membrane [6,8]. The central function of the V-
ATPase is to pump protons from the cytoplasm to the lumen of
organelles. In some specialized cells, the V-ATPase can also be found
at the plasma membrane. Its role is then either to acidify the
extracellular medium such as around osteoclasts and renal cells
[9,10,11], or to control the cytoplasmic pH as in neutrophiles and
macrophages [12,13]. The proton pump also appears to be involved
in cancer through the promotion of metastasis and tumor progression
and it is therefore considered as a potential drug target [6,13].
Despite the importance of the V-ATPase in physiological and
pathological processes, the exact mechanisms that control the
activity of the V-ATPase remain to be fully elucidated. Four
regulatory mechanisms have been described to date. The first is
the reversible dissociation of the catalytic V1 domain from the
membrane-associated V0, which was observed in S. cerevisiae and
Manduca sexta upon glucose deprivation and starvation respectively
[14,15]. Change in V1/V0 association was also reported during
maturation of murine dendritic cells [16]. The second mechanism
involves the abundance of the proton pump at a given site. In cells
such as renal cells and osteoclasts, where the proton pump is at the
cell surface, acid secretion was indeed found to be modulated by a
differential surface expression of the V-ATPase through reversible
exocytosis and endocytosis of the pump [17]. The third
mechanism by which the activity of the V-ATPase could be
modulated is by changing of the coupling efficiency between ATP
hydrolysis and proton translocation, attributable to different
isoforms of subunit V0a. This differential coupling efficiency was
proposed to explain that lysosomes are more acidic than the Golgi
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[1,6,18] [19]. Finally, it has been proposed that specific lipids can
affect the activity of the V-ATPase. More specifically it was shown
in yeast that sphingolipids with a C26 acyl group are required for
generating V1 domains with ATPase activity [20]. Interestingly,
several V-ATPase inhibitors where shown to incorporate into the
lipid bilayer and affect the V-ATPase structural flexibility [21,22].
In this study, our interest was to get a better understanding of
how pH is controlled along the endocytic pathway in mammalian
cells, since most studies on V-ATPase regulation where performed
in yeast. We found that the increased acidity of late endosomes is
not due to a higher density of proton pumps but rather to an
increase in the V1/V0 ratio when compared to early endosomes.
Thus regulation would occur via reversible association/dissocia-
tion, reminiscent of what occurs found in yeast. Additionally, we
found that the lipid environment of the V-ATPase is of essential
importance for its activity, suggesting a second mode of regulation
and highlighting that the V-ATPase activity is modulated by
multiple, simultaneously operating, mechanisms.
Results
DRM association of all the subunits of the V-ATPase
Endosomes, and in particular late endosomes, are well known to
be composed of mosaics of domains [23,24]. We have shown that
late endosomes, in particular, contain raft-like domains that are
rich in cholesterol and sphingomyelin and resistant to extraction in
non-ionic detergents at 4uC [25,26]. To further characterize late
endosomal DRMs, we have here performed a proteomic analysis.
Proteomics analysis of DRM fractions have been reported in
numerous studies [27,28,29,30,31], but this is the first that
proteomics was performed on DRMs of a purified endocytic
organelle. As previously, late endosomes were obtained from Baby
Hamster Kidney cells, since a well-established subcellular
fractionation protocol to purify late endosomes is available for
this cell line [25,32]. We have previously shown using surface
biotinylation of proteins that this fraction does not contain
detectable amounts of plasma membrane [33]. Moreover this late
endosomal fraction is not contaminated by Golgi, endoplasmic
reticulum, early endosomal or caveolar membranes, as shown by
western blotting using marker proteins [34]. It is likely that the
high purity of this fraction is due to the fact that the late
endosomal fraction has a very low buoyancy and thus migrates
through the entire gradient to the top of the tube, far away from all
other cellular compartments. The llate endosomal fraction was
subsequently submitted to solubilization in triton X-100 at 4uC
and the Detergent-Resistant-Membranes (DRMs, fractions 1 and
2 from the top of the gradient) were separated from the Detergent-
Soluble-Membranes (DSMs, fractions 5 and 6) using floatation
gradients. The proteomes of both the DRMs and DSMs were
determined by mass spectrometry after appropriate trypsinization
and sample preparation.
Some 126 and 161 proteins were identified in the DRM and
DSM fractions respectively, 44 of which were found in both
fractions (Table 1 and 2), which jointly provide a global proteome of
the organelle. Reassuringly, known late endosome specific proteins
such as the small GTPase Rab7, the lysosomal glycoprotein
LAMP2, or the NPC1 protein involved in Niemann Pick type C
disease [35] were found. Also the DRM fraction contained most of
the well-documented rafts markers such as caveolin-1 and 2 –
involved in the formation of caveolae, in signaling and in lipid
regulation [36]–, erlin 2, –a DRM associated ER protein [37],
flotillins 1 and 2 [38], which were also found in the DSM in
agreement with detectable amounts by western blotting [25],
stomatin and the hyaluronic acid receptor CD44 [39].
As illustrated in Fig. 1, proteins forming the largest group, in
both fractions, were involved in trafficking, confirming that late
endosomes are implicated in intensive communication with other
compartments. In particular, several small GTPases of the Rab
family, in addition to Rab7 well known to localize to late
endosomes, were found, in agreement with other proteomic
studies [40] and suggesting a more complex role/localization of
Rabs than expected.
Interestingly many of the identified proteins were involved in
signaling, in particular in the DRMs, such as the a and ß subunits
of several G proteins, as also reported by others reported [40,41].
The presence of these proteins in late endosomes supports the
notion that endosomes are active signaling sites [42] and that
cholesterol rich domains are important in organizing signaling
platforms [43].
However, the most striking finding to us was the identification of
all the subunits of the V-ATPase (a1, c and d from the V0 subunit
and A, B2, C, D, E, F, G2 and H from the V1 subunit) exclusively
in the DRM fraction. This observation suggested that the V-
ATPase may localize to specific membrane domains within late
endosomes and that this could be important for its function or the
regulation of its activity.
There is increasing evidence that the V-ATPase can interact
with numerous regulatory proteins, and thus we investigated
whether some of these proteins came up in our proteomics
analysis. The H-subunit, which shows homology to ß-adaptins
[44], was found to interact with the m2-chain of AP2 adaptor and
promotes clathrin-coated vesicle (CCV) formation [44]. Interest-
ingly we found three of the subunits of the adaptor complex AP-2,
in the late endosomal DRM fraction. Functional AP-2 complex
was previously observed in lysosomes and found to support
clathrin assembly and bud formation [45,46]. We also found the
small GTPase Arf6, albeit in DSM fraction. Arf6 was found to
interact with the Vo c subunit and it was proposed that through
this interaction, the vATPase could modulate membrane traffick-
ing in the endosomal system [47]. In addition to mediating proton
transport, it has been proposed that the Vo subunit is involved in
vesicles fusion both in yeast [48] and in higher eukaryotes [49,50].
Numerous proteins involved in membrane fusion were found in
the DRM fraction including SNAP-23, syntaxin 8, VAMP-A and
the v-SNARE like protein Vtil-rp1.
Finally the dissociation of the V1/vo complex, in yeast, has been
shown to require an intact microtubule network [51] and well
aldolase, which would act as a glucose sensor and signal for the
dissociation of the V-ATPase [52]. Both tubulin and aldolase were
detected in our proteomic analysis. Interestingly aldolase was only
found in the DSM fraction and it is tempting to speculate that
spatial segregation between the V-ATPase and aldolase is
necessary to prevent uncontrolled disassembly of the complex.
Clearly, non transmembrane proteins could also be removed from
the detergent resistant domains during the solubilization.
DRM association of the V-ATPase
To validate the DRM association of the V-ATPase revealed by
the proteomic analysis, we performed a Western blot analysis
probing for V-ATPase subunits of the V1 and V0 domains.
Distribution of the V0 domain was monitored by following the d
subunit and distribution of the V1 domain by following the A
subunit. Both V0d and V1A subunits were found in the DRM
fractions of both late endosomes and early endosomes (Fig. 2).
Note that the total protein content of each fraction was analyzed in
Fig. 2, as opposed to the same amount of protein. Fig. 2 thus shows
that the majority of the V-ATPase localized to DRMs, showing a
Regulation of the V-ATPase
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Table 1. Proteins identified in the late endosomal DRM fraction.
Numb Uniprot Numb Protein name Protein family Mascot score Mw Cov (%) Nb pep
1 P56564 Excitatory amino acid transporter 1 AA transport 150.46 59584 7.21 2
2 Q3UFR4 Neutral amino acid transporter ASCT2 AA transport 186.95 58327 6.42 3
3 Q9JKY1 Peroxiredoxin-1 Cell redox homeostasis 45.56 22248 5.45 1
4 Q71FK5 Actin, cytoplasmic 1 (Beta-actin) Cytoskeleton 1034.51 41710 54.35 15
5 P63260 Actin, cytoplasmic 2 (Gamma-actin) Cytoskeleton 1071.66 41766 54.35 15
6 Q7TSH1 Actr3b protein Cytoskeleton 55.1 48539 2.49 1
7 Q8BMK4 Cytoskeleton-associated protein 4 Cytoskeleton 74.92 60655 2.9 1
8 P47757 F-actin-capping protein subunit beta Cytoskeleton 44.23 31195 3.53 1
9 Q5M810 Myo1g protein Cytoskeleton 114.37 58945 7.1 2
10 Q3UFT0 myosin heavy chain IX Cytoskeleton 108.31 110908 4.27 2
11 Q63355 Myosin I heavy chain Cytoskeleton 1530.65 118017 27.33 23
12 P14869 Myosin regulatory light chain 2-A Cytoskeleton 80.24 34195 3.87 1
13 P46735 Myosin-Ib Cytoskeleton 45.16 128447 0.77 1
14 Q9ERB6 Nuclear myosin I beta Cytoskeleton 1508.15 119802 27.09 23
15 P30427 Plectin-1 Cytoskeleton 42.29 533214 0.23 1
16 Q9EPK2 Protein XRP2 Cytoskeleton 39.92 39220 3.93 1
17 P54116 Stomatin Cytoskeleton 192.32 31384 15.79 3
18 P68372 Tubulin beta-2C chain Cytoskeleton 144.93 49799 6.42 3
19 Q3TWV0 vimentin Cytoskeleton 97.46 53633 4.72 2
20 Q8K3H8 Calnexin ER chaperone 48.48 67422 2.61 1
21 Q8BFZ9 Erlin-2 precursor ERAD pathway 129.07 37849 10.76 3
22 O08917 Flotillin-1 Flotillin complex 900.61 47484 42.92 14
23 Q9Z2S9 Flotillin-2 Flotillin complex 782.94 47009 34.43 12
24 P17809 Glucose transporter type 1 (GLUT-1) Glucose transporter 105.89 53899 3.68 2
25 Q3UAZ6 ATP-binding cassette, sub-family B (MDR/TAP),
member 6
Heme homeostasis 41.06 84765 1.95 1
26 O88783 Coagulation factor V Ion binding 43.16 247076 0.45 1
27 Q6PFA8 Moxd1 protein Ion binding 89.33 69734 3.63 2
28 Q3TVE3 similar to S100 calcium-binding protein A16 Ion binding 49.01 14287 8.53 1
29 Q7TMC7 Ab2-417 (Cc1-8) Ion transport 97.43 107343 3.08 2
30 P51881 ADP/ATP translocase 2 Ion transport 92.37 32779 7.74 2
31 Q8VDN2 Na(+)/K(+) ATPase alpha-1 subunit Ion transport 634.88 112910 14.91 10
32 Q3TX38 voltage-dependent anion channel 3 Ion transport 143.97 30733 12.19 3
33 Q9Z2L0 Voltage-dependent anion-selective channel
protein 1 (VDAC-1)
Ion transport 107.19 30606 7.55 2
34 Q60930 Voltage-dependent anion-selective channel
protein 2 (VDAC-2)
Ion transport 49.07 31713 4.07 1
35 O08532 Voltage-dependent calcium channel subunit
alpha-2/delta-1
Ion transport 508.19 124551 12.37 9
36 P51909 Apolipoprotein D Lipid biogenesis 58.56 21596 6.12 1
37 Q9JKU9 Sigma 1 receptor beta variant Lipid biogenesis 42.74 21589 6.63 1
38 P00762 Anionic trypsin-1 precursor Peptidase 81.74 25943 8.51 1
39 P07356 Annexin A2 Phospholipid binding/
modifying
339.59 38521 24 6
40 Q8BG11 cadherin 13 Protein binding 43.41 78137 2.39 1
41 Q8BFU4 GAIP/RGS19 short isoform Protein binding 48.57 22240 6.44 1
42 Q4FCR4 Intercellular adhesion molecule 1 Protein binding 72.74 53809 2.86 1
43 P70490 Lactadherin precursor Protein binding 43.23 47382 2.56 1
44 Q6DI58 Rpl12 protein Protein binding 53.03 22973 7.21 1
45 Q6PDW1 40S ribosomal protein S12 Protein biosynthesis 108.17 14505 16.79 1
46 P62629 Elongation factor 1-alpha 1 Protein biosynthesis 50.37 50082 5.27 1
47 Q3U561 ribosomal protein L10A Protein biosynthesis 70.68 24800 5.78 1
Regulation of the V-ATPase
PLoS ONE | www.plosone.org 3 July 2008 | Volume 3 | Issue 7 | e2758
Numb Uniprot Numb Protein name Protein family Mascot score Mw Cov (%) Nb pep
48 Q3UBI6 ribosomal protein L7 Protein biosynthesis 53.16 31331 3.87 1
49 Q9QWC2 Ribosomal protein P2 Protein biosynthesis 40.29 5063 23.08 1
50 Q3UCL7 ribosomal protein S3 Protein biosynthesis 136.27 26658 16.12 3
51 Q62186 Translocon-associated protein subunit delta
precursor
Protein biosynthesis 61.03 18924 6.4 1
52 Q3S4T7 78 kDa glucose-regulated protein precursor Protein folding 268.69 72284 8.68 5
53 P24369 Cyclophilin B Protein folding 38.8 22699 6.31 1
54 P30412 Cyclophilin C Protein folding 253.35 22780 22.71 4
55 Q3KQJ4 Hspa8 protein (Fragment) Protein folding 252.63 62117 8.87 5
56 Q6AYQ9 Peptidyl-prolyl cis-trans isomerase Protein folding 211.16 22995 20.1 4
57 P62858 40S ribosomal protein S28 Protein processing 60.75 7836 16.9 1
58 Q9R0Y5 Adenylate kinase isoenzyme 1 Protein processing 51.75 21526 6.67 1
59 Q9WU83 Dolichol-phosphate mannosyltransferase Protein processing 42.88 29636 4.09 1
60 P57716 Nicastrin precursor Protein processing 43.83 78441 2.24 1
61 Q6AXQ3 Viral oncogene yes-1 homolog 1 Protein processing 249.57 54236 14 5
62 P25286 V0 subunit a1 Proton transport 419.99 96265 9.03 7
63 Q5XK06 V0 subunit C Proton transport 45.38 20434 9.73 1
64 P51863 V0 subunit d Proton transport 210.04 40275 7.92 3
65 Q3U5W3 V1 subunit A, isoform 1 Proton transport 790.08 68211 30.97 13
66 P62814 V1 subunit B2 (brain isoform) Proton transport 639.65 56515 29.82 12
67 Q9Z1G3 V1 subunit C Proton transport 176.41 43702 10.08 3
68 P57746 V1 subunit D Proton transport 47.54 28351 6.23 1
69 Q3UK59 V1 subunit E isoform 1 Proton transport 357.23 26145 27 5
70 Q9D1K2 V1 subunit F Proton transport 91.08 13362 17.36 2
71 Q8R2H0 V1 subunit G2 Proton transport 165.4 13659 12.9 2
72 Q8BVE3 V1 subunit H Proton transport 38.7 55819 3.16 1
73 P63001 Ras-related C3 botulinum toxin substrate 1 Ras-related protein 345.83 21436 32.47 6
74 Q99JI6 Ras-related protein Rap-1b precursor Ras-related protein 291.41 20812 32.28 5
75 P61226 Ras-related protein Rap-2b precursor Ras-related protein 142.64 20491 20.43 2
76 P62071 Ras-related protein R-Ras2 precursor Ras-related protein 125.1 23385 13.21 2
77 Q60522 CD44 antigen precursor Receptor 127.99 46778 5.41 2
78 P17852 Integrin alpha-3 precursor Receptor 150.39 118475 2.79 2
79 Q9ERD4 Ankyrin repeat-rich membrane-spanning protein Signalling 45.27 190414 1.21 1
80 P32261 Antithrombin-III precursor (ATIII) Signalling 68.51 51971 2.54 1
81 Q7TMA5 Apolipoprotein B-100 Signalling 276.81 535688 1.36 5
82 P61022 Calcium-binding protein p22 Signalling 93.05 22287 13.86 2
83 P62204 Calmodulin Signalling 331.96 16696 54.97 4
84 Q9DAS9 G protein G(I)/G(S)/G(O) subunit gamma-12 precursor Signalling 40.48 7861 22.54 1
85 P62874 G protein G(I)/G(S)/G(T) subunit beta-1 Signalling 195.17 37222 10.06 2
86 P62880 G protein G(I)/G(S)/G(T) subunit beta-2 Signalling 171.96 37176 10.09 2
87 P38403 G protein G(k) subunit alpha (G(i) alpha-3) Signalling 177.74 40447 11.44 3
88 P08752 Guanine nucleotide-binding protein G(i) Signalling 264.43 40314 14.21 4
89 Q6R0H7 Guanine nucleotide-binding protein G(s) subunit
alpha isoforms
Signalling 206.68 121429 3.26 4
90 Q3U2W7 Kirsten rat sarcoma oncogene 2 Signalling 67.25 21400 6.19 1
91 P62977 Ubiquitin Signalling 112.42 8560 32.47 2
92 Q6IN24 Galectin 8 sugar binding 96.51 36050 5.81 2
93 Q9CQW2 ADP-ribosylation factor-like protein 8B Trafficking 77.66 21525 19.49 2
94 P17426 AP-2 complex subunit alpha-1 Trafficking 110.59 107596 2.45 2
95 Q9DBG3 AP-2 complex subunit beta-1 Trafficking 92.4 104516 4.95 2
Table 1. Cont.
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distribution similar to that of Flotillin-1, a well-established marker
of DRM fractions [38].
Effects of U18666A treatment on the acidification of late
endosomes
The above experiments show that all along the endocytic
pathway, from early to late endosomes, the V-ATPase exhibits a
strong affinity for DRMs suggesting its preference for cholesterol
rich, ordered membrane domains. To evaluate the physiological
relevance of these findings, we investigated whether perturbing
cholesterol rich domains in late endosomes would affect the
function of the V-ATPase, by monitoring the acidity of late
endosomes.
We first investigated whether extraction of cholesterol from cells
using ß-methylcyclodextrin (ß-MCD) would lead to a change in
late endosome acidification. Cells were treated with 10 mM ß-
MCD for 55 min leading to an <50% decrease in total cholesterol
content [53]. As illustrated in Fig. S1, ß-MCD treatment led to a
significant increase in late endosomal pH, supporting the notion
that alteration of cholesterol rich domains affects the function of
the V-ATPase. These findings however need to be taken with a
word of caution, since we have no evidence that extraction of
cholesterol from the plasma membrane actually leads to a
significant reduction of cholesterol in late endosomes. Indeed
when purifying late endosomes from ß-MCD treated cells, we
could not detect a significant change in cholesterol, as analyzed by
thin layer chromatography, a technique that might not be sensitive
enough to detect small changes (10–20%). We therefore decided to
induce perturbation of late endosomal membrane domains by
treating cells with the negatively charged amine 3beta-(2-
diethylaminoethoxy)-androstenone HCl (U18666A) [54], which
leads to the accumulation of cholesterol in late endosomes,
through unknown mechanisms, and to alterations in the
membrane dynamics of this compartment [34]. Treatment for
18 hrs with U18666A mimics the Niemann Pick type C phenotype
Numb Uniprot Numb Protein name Protein family Mascot score Mw Cov (%) Nb pep
96 P62743 AP-2 complex subunit sigma-1 Trafficking 50.54 17007 9.74 1
97 P49817 Caveolin-1 Trafficking 289.28 20525 40.32 6
98 Q8VIK7 Caveolin-2 Trafficking 46.57 18163 9.7 1
99 P08712 Endoplasmin Trafficking 41.48 46765 3.29 1
100 Q6WRU0 GPI-anchored protein GREG Trafficking 49.7 22812 5.31 1
101 Q5SW87 RAB1 Trafficking 144.33 15016 27.94 3
102 Q4FJL0 RAB10 Trafficking 129.62 22527 16.67 3
103 Q91V41 RAB14 Trafficking 51.95 23751 6.05 1
104 P35293 RAB18 Trafficking 48.64 23021 5.26 1
105 P53994 RAB2A Trafficking 177.51 23533 20.19 3
106 P61021 RAB5B Trafficking 36.86 23692 6.51 1
107 Q3TCT9 RAB5C Trafficking 132.96 23397 21.23 3
108 Q3U4W5 RAB6 Trafficking 41.42 23531 5.63 1
109 Q4AEF6 RAB7 Trafficking 163.59 23489 17.37 3
110 P13596 RAB7a Trafficking 140.11 94599 3.49 2
111 P63321 Ral-A precursor Trafficking 121.59 23538 12.68 3
112 Q3UZ06 SEC22 vesicle trafficking protein-like 1 Trafficking 67.84 18935 6.98 1
113 O70377 SNAP-23 Trafficking 84.91 23220 18.48 2
114 Q5F234 Syntaxin 8 Trafficking 66.07 26908 7.38 1
115 O35587 Transmembrane protein Tmp21 precursor Trafficking 90.42 24805 8.89 2
116 Q9WV55 VAMP-associated protein A (VAMP-A) Trafficking 93.96 27262 5.67 2
117 O88384 Vesicle transport v-SNARE protein Vti1-like 1 (Vti1-rp1) Trafficking 53.28 26697 4.96 1
118 Q791V5 Mitochondrial carrier homolog 2 Tranporter 52.55 33477 7.89 1
119 O54724 Polymerase I and transcript release factor Transcription 138.19 43927 7.27 2
120 Q9Z239 Phospholemman precursor Unknown cellular process 52.05 10316 12.9 1
121 Q3TH64 Q3TH64 Unknown cellular process 40.29 16236 23.13 1
122 Q6UL10 Q6UL10 Unknown cellular process 45.96 223986 0.59 1
123 Q9QUR8 Semaphorin-7A precursor Unknown cellular process 60.59 74946 1.91 1
124 Q3TJK3 serine (or cysteine) proteinase inhibitor Unknown cellular process 119.34 46505 9 2
125 Q3TIP1 solute carrier family 3 Unknown cellular process 40.75 10997 17.17 1
126 Q6P791 UPF0404 protein C11orf59 homolog Unknown cellular process 137.22 17710 16.25 2
Mw: theoretical molecular weight (kDa). Cov (%), protein sequence coverage; Nb pep, number of peptides assigned. In bold are the proteins found in both DRM and
DSM fractions.
doi:10.1371/journal.pone.0002758.t001
Table 1. Cont.
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Table 2. Proteins identified in the late endosomal DSM fraction.
Numb Uniprot Numb Protein name Protein family Mascot scoreMw Cov (%) Nb pep
1 Q60458 Cationic amino acid transporter-1 AA transport 97.13 35185 11.6 2
2 Q8VII6 Choline transporter-like protein 1 AA transport 47.02 73043 1.81 1
3 Q3UFR4 Neutral amino acid transporter ASCT2 AA transport 174.62 58327 6.42 3
4 P17897 Lysozyme C type P precursor Bacteriolytic 49.06 16783 7.89 1
5 Q920L2 Succinate dehydrogenase [ubiquinone] flavoprotein
subunit
Carbohydrate metabolism 55.31 71570 2.15 1
6 Q9Z0G9 Claudin-3 Cell adhesion 85.27 23269 13.27 2
7 Q3T1H3 Ncam1 protein Cell adhesion 400.3 93515 11.65 6
8 Q91Z81 ERP57 protein Cell redox homeostasis 493.44 56761 20.93 9
9 P20070 NADH-cytochrome b5 reductase 3 Cell redox homeostasis 243.98 34022 12.94 4
10 Q60451 NADPH-cytochrome P450 oxidoreductase Cell redox homeostasis 46.89 75803 1.6 1
11 Q52KJ9 Thioredoxin domain containing 1 Cell redox homeostasis 120.38 31415 10.53 2
12 Q3THH1 thioredoxin domain containing 5 Cell redox homeostasis 326.36 48627 11.54 4
13 Q71FK5 Actin, cytoplasmic 1 (Beta-actin) Cytoskeleton 583.76 41710 37.2 10
14 P18760 Cofilin-1 Cytoskeleton 111.27 18417 13.77 2
15 P47753 F-actin-capping protein subunit alpha-1 Cytoskeleton 54.64 32788 3.36 1
16 P62962 Profilin-1 Cytoskeleton 50.02 14816 10.45 1
17 P54116 Stomatin Cytoskeleton 48.34 31384 4.21 1
18 P68361 Tubulin alpha-1B chain Cytoskeleton 55.57 50120 1.98 1
19 P69893 Tubulin beta-5 chain Cytoskeleton 115.73 49639 4.43 2
20 P02544 Vimentin Cytoskeleton 305.99 53566 11.93 5
21 Q8K3H8 Calnexin ER chaperone 119.25 67224 5.07 2
22 O08917 Flotillin-1 Flotillin complex 383.61 47484 20.19 6
23 Q9Z2S9 Flotillin-2 Flotillin complex 445.33 47009 20.84 7
24 Q9Z1W7 GP50 Folding and Transport
regulator
264.19 46569 14.89 4
25 Q3TWF2 heat shock 70kD protein 5 Folding and Transport
regulator
909.11 72419 27.66 15
26 P19378 Heat shock cognate 71 kDa protein Folding and Transport
regulator
500.69 70761 16.49 9
27 P35293 Heat shock protein HSP 90-beta Folding and Transport
regulator
44.7 23021 5.26 1
28 P17809 Glucose transporter type 1 (GLUT-1) Glucose transporter 51.34 53899 1.64 1
29 P05064 Fructose-bisphosphate aldolase A Glycolysis 64.07 39200 5.62 1
30 Q3THM2 glyceraldehyde-3-phosphate dehydrogenase Glycolysis 91.15 35789 8.11 2
31 O70252 Heme oxygenase 2 Heme homeostasis 85.89 35716 12.35 2
32 Q1MWP8 EH-domain containing 4-KJR Ion binding 38.62 61613 1.96 1
33 Q3U7R1 Extended-synaptotagmin-1 (E-Syt1) Ion binding 114.58 121478 2.63 2
34 Q6PFA8 N-acylsphingosine amidohydrolase 1 Ion binding 45.67 69734 1.58 1
35 Q05186 Reticulocalbin-1 precursor Ion binding 42.58 38090 4.34 1
36 Q7TMC7 Ab2-417 (Cc1-8) Ion transport 110.61 107343 2.97 2
37 Q3V132 ADP/ATP translocase 4 Ion transport 47.67 35235 3.75 1
38 P15999 ATP synthase subunit alpha Ion transport 58.99 59717 2.21 1
39 P56480 ATP synthase subunit beta Ion transport 140.84 56265 5.09 2
40 O55143 endoplasmic reticulum calcium ATPase 2 Ion transport 107.98 114784 3.45 2
41 Q09143 High affinity cationic amino acid transporter 1 Ion transport 98.32 67048 3.94 2
42 Q91VS7 Microsomal glutathione S-transferase 1 Ion transport 83.61 17409 7.59 1
43 Q8VDN2 Na(+)/K(+) ATPase alpha-1 subunit Ion transport 621.11 112910 16.37 10
44 P11505 Plasma membrane calcium-transporting ATPase 1 Ion transport 522.49 138632 10.32 11
45 Q3TX38 voltage-dependent anion channel 3 Ion transport 232.58 30733 19.35 4
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46 Q9Z2L0 Voltage-dependent anion-selective channel
protein 1 (VDAC-1)
Ion transport 245.29 30606 23.38 5
47 Q60930 Voltage-dependent anion-selective channel
protein 2 (VDAC-2)
Ion transport 177.68 31713 14.93 3
48 P51909 Apolipoprotein D Lipid biogenesis 62.59 21596 6.12 1
49 Q8BLF1 Arylacetamide deacetylase-like 1 Lipid biogenesis 122.47 45711 5.06 2
50 O88531 Palmitoyl-protein thioesterase 1 precursor Lipid biogenesis 80.12 34467 4.79 1
51 Q9JKU9 Sigma 1 receptor beta variant Lipid biogenesis 52.54 21589 6.63 1
52 Q9R1J0 Sterol-4-alpha-carboxylate 3-dehydrogenase Lipid biogenesis 42.14 40660 3.52 1
53 Q69ZN7 Myoferlin (Fer-1-like protein 3) Membrane repair 152.49 236053 2.38 3
54 Q99KV1 DnaJ homolog subfamily B member 11 precursor mRNA modification 41.04 40530 2.99 1
55 P00762 Anionic trypsin-1 precursor Peptidase 81.51 25943 8.51 1
56 P07150 Annexin A1 Phospholipid binding/
modifying
223.58 38674 7.12 3
57 P07356 Annexin A2 Phospholipid binding/
modifying
934.99 38521 40.57 14
58 Q3UCL0 annexin A4 Phospholipid binding/
modifying
177.72 35893 9.51 3
59 P48037 Annexin A6 Phospholipid binding/
modifying
367.61 75575 14.26 8
60 P14824 Annexin A6 Phospholipid binding/
modifying
359.86 75707 13.66 8
61 Q8VDP6 Phosphatidylinositol synthase Phospholipid binding/
modifying
37.88 23583 5.14 1
62 Q8R366 Immunoglobulin superfamily member 8 precursor Protein binding 115.51 64970 3.73 2
63 Q4FCR4 Intercellular adhesion molecule 1 Protein binding 186.97 53809 8.38 3
64 P21956 Lactadherin precursor Protein binding 47.39 51236 2.37 1
65 P70117 Pancreas cancer-associated protein 4 Protein binding 166.84 64358 6.67 3
66 P70206 Plexin-A1 precursor Protein binding 75.36 210965 1.3 2
67 Q9WV91 Prostaglandin F2 receptor negative regulator
precursor
Protein binding 91.15 98646 3.46 2
68 Q5SS40 Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein
Protein binding 50.26 29155 4.91 1
69 P62629 Elongation factor 1-alpha 1 Protein biosynthesis 208.12 50082 12.97 4
70 P10630 Eukaryotic initiation factor 4A-II Protein biosynthesis 40.71 46373 2.38 1
71 Q66H94 Peptidyl-prolyl cis-trans isomerase (PPIase) Protein biosynthesis 44.5 63086 2.09 1
72 Q8R2Y8 Peptidyl-tRNA hydrolase 2 (PTH 2) Protein biosynthesis 50.9 19514 7.82 1
73 Q9CY50 Translocon-associated protein subunit alpha
precursor
Protein biosynthesis 44.77 32045 5.15 1
74 Q62186 Translocon-associated protein subunit delta
precursor
Protein biosynthesis 58.73 18924 6.4 1
75 Q60432 150 kDa oxygen-regulated protein Protein folding 111.56 111202 3.56 2
76 Q1PSW2 84 kDa heat shock protein Protein folding 268.13 83230 5.29 4
77 P24369 Cyclophilin B Protein folding 159.73 22699 17.96 3
78 P30412 Cyclophilin C Protein folding 111.37 22780 12.08 2
79 Q8R180 ERO1-like protein alpha precursor (ERO1-Lalpha) Protein folding 40.76 54004 2.45 1
80 Q3U5T8 t-complex protein 1 Protein folding 97.92 55438 4.17 2
81 P80318 T-complex protein 1 subunit gamma Protein folding 82.19 60591 2 1
82 O70152 Dolichol-phosphate mannosyltransferase Protein processing 41.77 29156 8.3 1
83 Q3UC51 dolichyl-di-phosphooligosaccharide-protein
glycotransferase
Protein processing 197.03 49011 9.44 4
84 Q03145 Ephrin type-A receptor 2 precursor Protein processing 77.94 108753 2.73 2
85 O08795 Glucosidase 2 subunit beta precursor Protein processing 42.18 58756 1.87 1
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86 P17439 Glucosylceramidase precursor Protein processing 81.57 57585 4.59 2
87 P57716 Nicastrin precursor Protein processing 48.9 78441 1.54 1
88 P27773 Protein disulfide-isomerase A3 precursor Protein processing 421.29 56586 18.29 8
89 P38660 Protein disulfide-isomerase A6 precursor Protein processing 264.65 48131 11.67 3
90 Q8R4U2 Protein disulfide-isomerase precursor (PDI) Protein processing 516.21 56975 27.85 9
91 P52480 Pyruvate kinase isozymes M1/M2 Protein processing 257.65 57719 14.89 5
92 Q91YQ5 Ribophorin I Protein processing 47.47 68486 1.93 1
93 Q9DBG6 Ribophorin II Protein processing 97.57 69020 3.67 2
94 Q00993 Tyrosine-protein kinase receptor UFO precursor Protein processing 70.28 98188 1.23 1
95 Q6AXQ3 Viral oncogene yes-1 homolog 1 Protein processing 36.55 54236 4.46 1
96 Q3TFU8 Glycoprotein 25L2 homolog Protein transport 89.06 31239 7.42 2
97 P62835 Rap-1A precursor Ras-related protein 240.69 20974 18.42 4
98 P80236 Ras-related C3 botulinum toxin substrate
1 (p21-Rac1)
Ras-related protein 47.41 8805 17.5 1
99 P61226 Ras-related protein Rap-2b precursor Ras-related protein 69.2 20491 6.45 1
100 P62071 Ras-related protein R-Ras2 precursor Ras-related protein 79.46 23385 7.55 1
101 Q61411 Transforming protein p21 (p21ras) Ras-related protein 49.31 21335 6.22 1
102 P17852 Integrin alpha-3 precursor Receptor 329.02 118475 6.59 5
103 P43406 Integrin alpha-V precursor Receptor 120.21 115205 2.87 3
104 P09055 Integrin beta-1 precursor Receptor 90.71 88173 2.5 2
105 P61022 Calcium-binding protein p22 Signalling 58.15 22287 5.94 1
106 P62204 Calmodulin Signalling 187.09 16696 30.46 3
107 P62874 G protein G(I)/G(S)/G(T) subunit beta-1 Signalling 186.51 37222 13.02 3
108 P62880 G protein G(I)/G(S)/G(T) subunit beta-2 Signalling 151 37176 13.06 3
109 Q3HR13 Guanine nucleotide binding protein alpha
inhibiting 2
Signalling 235.3 40419 14.17 4
110 Q5EAP4 Guanine nucleotide binding protein, alpha 14 Signalling 227.12 41415 12.5 4
111 P21279 Guanine nucleotide-binding protein G(q) subunit
alpha
Signalling 273.99 41457 20.21 5
112 Q8R4A8 Guanine nucleotide-binding protein G(s) subunit
alpha
Signalling 232.48 45621 13.04 5
113 P62977 Ubiquitin Signalling 114.62 8560 32.47 2
114 O88736 3-keto-steroid reductase Steroid metabolism 58.55 37293 3.54 1
115 P47953 Galectin-3 Sugar binding 50.42 25592 4.31 1
116 Q3U0D7 ADP-ribosylation factor 6 Trafficking 37.23 20069 6.04 1
117 Q9CQW2 ADP-ribosylation factor-like protein 8B Trafficking 205.81 21525 17.44 4
118 Q9DB05 Alpha-soluble NSF attachment protein (SNAP-alpha) Trafficking 173.24 33168 12.62 3
119 P49020 COPI-coated vesicle membrane protein p24 Trafficking 66.59 22175 6.47 1
120 P08113 Endoplasmin precursor Trafficking 334.23 92418 5.6 5
121 P49130 LAMP-2 Trafficking 41.5 44999 2.44 1
122 O35604 Niemann-Pick C1 protein precursor Trafficking 36.07 142795 1 1
123 Q91ZX7 Prolow-density lipoprotein receptor-related
protein 1 precursor (LRP)
Trafficking 107.05 504411 0.68 2
124 O35074 Prostacyclin synthase Trafficking 170.13 57011 7.34 3
125 Q9D0F3 Protein ERGIC-53 precursor Trafficking 52.6 57753 2.1 1
126 Q4FJL0 RAB10 Trafficking 174.32 22559 16.1 3
127 P62492 RAB11A Trafficking 51.03 24247 5.91 1
128 Q91V41 RAB14 Trafficking 99.99 23751 11.16 2
129 P62821 RAB1A Trafficking 187.04 22532 19.12 3
130 P53994 RAB2A Trafficking 263.69 23533 30.52 5
131 Q3UCX7 RAB5A Trafficking 80.78 23585 11.68 2
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[34,54,55] showing a drastic cholesterol accumulation in late
endosomes (Fig. 3CF and 4CF).
The pH measurements were performed by fluorescence ratio
imaging, using the pH sensitive florescent probe FITC (fluorescein
isothiocyanate) [56]. We used two different probes: FITC coupled
to dextran, which was endocytosed by fluid phase and thus
provides information on the bulk of the endosomal lumen, and
FITC coupled to a monoclonal antibody, 4A1, against the luminal
domain of the hamster late endosomal protein Lamp1. Lamp1
localizes specifically to the limiting membrane of late endosomes
[57] –this organelle being multivesicular [23]–, and thus FITC
anti-lamp1 allows the measurement of the pH in the vicinity of the
limiting membrane. We find that the 4A1 anti-Lamp1 antibody
internalized overnight (Fig. 3B, 3E), reaches late endosomes where
it binds to its antigen (co-localizing with the late endosomal lipid
LBPA, not shown) and is not degraded, in agreement with
observations by others [58,59]. In contrast, a none specific
antibody endocytosed at the same concentration was degraded in
late endosomes/lysosomes, as documented by others [59]. The
fluid phase fluorescent probe, FITC-Dextran was internalized for
159 and chased for 409 in order to reach late endosomes (Fig. 4B,
4E). Importantly we have previously shown that U18666A
treatment does not prevent transport to late endosomes [34].
Series of images were taken at both 440 nm and 490 nm, prior to
calibration with different pH solutions, which allows the
translation of ratio values into pH values. As illustrated by the
pseudocolor images (Fig. 3B, 4B) and quantified in the distribution
histograms (Fig. 3A, 4A), the pH of late endosomes in control cells
varied between 4.8560.40 and 5.0960.44 depending on the
probe used, a pH that was neutralized upon treatment with the V-
ATPase specific inhibitor bafilomycin (Fig. 3A). Late endosomes of
U18666A cells were however 0.41 (using anti-lamp1 FITC) to 0.88
Numb Uniprot Numb Protein name Protein family Mascot scoreMw Cov (%) Nb pep
132 P61021 RAB5B Trafficking 141.52 23692 20.47 3
133 Q3TCT9 RAB5C Trafficking 200.16 23398 23.11 4
134 Q3U4W5 RAB6 Trafficking 269.71 23531 28.64 5
135 Q4AEF6 RAB7 Trafficking 40.92 28557 3.47 1
136 Q3UZ06 SEC22 vesicle trafficking protein-like 1 Trafficking 97.82 18935 6.98 1
137 Q8K021 Secretory carrier membrane protein 1 Trafficking 40.66 38004 6.67 1
138 Q62465 Synaptic vesicle membrane protein VAT-1 homolog Trafficking 77.87 43069 3.58 1
139 O88385 Syntaxin 12 Trafficking 55.46 31090 5.32 1
140 Q3TSL5 syntaxin 4A Trafficking 76.27 34204 7.1 2
141 Q9JI92 Syntenin-1 Trafficking 109.68 32403 11.33 2
142 Q61235 Syntrophin-3 (SNT3) Trafficking 162.55 56346 7.42 3
143 Q07891 Transferrin receptor protein 1 (TfR) Trafficking 51.95 85027 1.42 1
144 O35587 Transmembrane protein Tmp21 precursor Trafficking 152.47 24805 16.44 3
145 P63024 Vesicle-associated membrane protein 3 (VAMP-3) Trafficking 55.54 11473 15.38 1
146 Q791V5 Mitochondrial carrier homolog 2 Transporter 71.58 33477 7.89 1
147 Q7TP91 Ab1-205 Unknown cellular process 50.91 83209 1.72 1
148 Q9D7N9 Adipocyte plasma membrane-associated protein Unknown cellular process 94.98 46405 5.46 2
149 P20944 CD44 antigen precursor Unknown cellular process 142.8 39750 4.99 2
150 Q9QV38 ERP6 Unknown cellular process 54.19 2112 73.68 1
151 Q8BLN5 Lanosterol synthase (EC 5.4.99.7) Unknown cellular process 68.6 83088 1.85 1
152 Q6P7S1 N-acylsphingosine amidohydrolase 1 Unknown cellular process 150.07 44415 10.42 3
153 P97300 Neuroplastin precursor Unknown cellular process 60.1 31258 3.52 1
154 Q9Z239 Phospholemman precursor Unknown cellular process 38.49 10316 12.9 1
155 O55221 Putative CD98 protein Unknown cellular process 63.88 58889 3.74 1
156 Q9JK11 Reticulon-4 Unknown cellular process 59.01 126310 1.13 1
157 Q9CWD1 similar to DB83 PROTEIN Unknown cellular process 66.14 19857 6.67 1
158 Q3TIP1 solute carrier family 3 Unknown cellular process 55.26 10997 17.17 1
159 Q5XIK2 Thioredoxin domain-containing protein 14
precursor
Unknown cellular process 39.08 33844 3.91 1
160 Q2TBF8 Transmembrane 9 superfamily protein member 4 Unknown cellular process 41.68 74584 1.33 1
161 Q6P791 UPF0404 protein C11orf59 homolog Unknown cellular process 116.65 17710 16.25 2
Mw: theoretical molecular weight (kDa). Cov (%), protein sequence coverage; Nb pep, number of peptides assigned. In bold are the proteins found in both DRM and
DSM fractions.
doi:10.1371/journal.pone.0002758.t002
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(using FITC dextran) pH units less acidic than late endosomes
from control cells, yet pH was still sensitive to bafilomycin,
suggesting that acidity was still mainly due to the V-ATPase.
We next analyzed the effect of U18666A biochemically,
monitoring the association of the V-ATPase subunits with
membranes. Post nuclear supernatant (PNS) from control and
U18666A treated BHK cells were submitted to high-speed
centrifugation to separate the membranes (P: pellet) from the
cytosol (SN: supernatant). As expected for a V0 domain subunit,
V0d was entirely membranes associated, irrespective of U18666A
treatment. In contrast, the majority of V1E was in the cytosolic
fraction of control cells with only a minor fraction associated with
membranes. Interestingly, this distribution was reversed upon
U18666A treatment, leading a two-fold increase in the membrane
to cytosol ratio of the V1E subunit (Fig. 5). This result indicates
that the lipid composition of the membrane, and possibly the
degree of order of the membrane, affects the V1-V0 association/
dissociation of the V-ATPase. The observations are compatible
with a higher V1 off rate in a more fluid membrane. The transport
of protons by the V-ATPase requires the association of the V1
sector with the V0. Therefore an increased association of V1 with
membranes as observed upon U18666A would a priori be
expected to lead to an increased activity and thus more acidic
endosomes. Yet U18666A led to a decrease in acidity. Together
these observations suggest that U18666A altered the dynamics of
association/dissociation, which appear to be essential for proper
Figure 1. Graphic representation of the main functional
categories found in the proteomic studies. A: DRM fraction, B:
DSM fraction.
doi:10.1371/journal.pone.0002758.g001
Figure 2. Association of V1 and V0 domains of the V-ATPase
with the DRMs of early and late endosomes. Late (A) and early (B)
endosomes were purified from BHK cells and the fractions were
submitted to solubilization in 1% triton X-100 at 4uC. The Triton X-100
treated fractions were subsequently loaded at the bottom of an
OptiPrep gradient. After centrifugation, 6 fractions were collected from
the top and analyzed by SDS-PAGE followed by Western blotting to
detect flotilin-1, Rab7, the vATPas subunits V0d and V1A.
doi:10.1371/journal.pone.0002758.g002
Figure 3. Effects of U18666A treatment on the pH at the
limiting membrane (FITC-Lamp1) of late endosomes. Lamp1-
FITC was internalized overnight at 37uC by control cells (A, B, C) and
cells treated by U18666A (D, E, F). Typical examples of the respective
labels are shown (B and E). The pH of individual organelles was
measured by fluorescence ratio imaging of internalized Lamp1-FITC.
The histograms show the pH distribution of 2304 and 2325 endosomes
for the upper and the lower panels, respectively, with the mean6SD
given in the left panels (A and D). Pseudocolor pH scale is on the side.
Histograms of vesicles of cells treated with bafilomycin are shown as a
control. The observed difference is significant according to a paired t-
test with p,0.001. Cells were checked for their phenotype of
cholesterol accumulation with filipin staining (C and F). Bars, 10 mm.
doi:10.1371/journal.pone.0002758.g003
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V-ATPase function, leading to a locked configuration of the V-
ATPase.
Increase of the V1/V0 ratio along the endocytic pathway
The above observation suggests that the membrane environ-
ment influences the activity of the V-ATPase. This does not
exclude other mechanisms of regulation and in particular we
found that the V-ATPase was associated with DRMs in both early
and late endosomes, rendering it unlikely that membrane
localization is the sole responsible for the different pH in early
and late endosomes. We therefore investigate whether association/
dissociation of the V1 domain form the V0 domain, the regulatory
mechanism found in yeast, could contribute to the increase in
acidity along the endocytic pathway. Early and late endosomes
fractions, enriched in the transferrin receptor and the late
endosomal lipid lysobisphosphatidic acid (LBPA, used a marker
of late endosomes) respectively (Fig. 6A and 6B), were obtained by
differential centrifugation from BHK cells and separated from
heavy membranes containing the endoplasmic reticulum and the
Golgi (Fig. 6). As expected, the V0 and V1 subunits, revealed with
anti- V0d and anti-V1B respectively, were detected in both early
and late endosomes (Fig. 6A). As observed through the analysis of
multiple experiments, the enrichment of the V0 subunit d was
quite similar in early and late endosomes indicating that the
density of the proton translocator subunit was the same in both
compartments (not shown). What was strikingly different between
early and late endosomes was however the relative abundance of
the V1 domain, as witness by following the B (Fig. 6A), the A or E
subunits (data not shown): the V1/V0 ratio was always higher in
late than in early endosomes, as quantified from several
experiments in Fig. 6B (n= 3, note that the ratios only have a
relative meaning and do not provide stochiometric information
because the antibodies against the two subunits are by definition
different). The higher V1/V0 ratio in late vs. early endosomes
correlates with the higher acidity of this compartment, suggesting
that an increase in V-ATPase activity through an increase in V1-
V0 association is the underlying mechanism and that this
mechanism of regulation is not restricted to yeast [14,60] and
maturing dendritic cells [16].
Discussion
Endosomes are the most acidic organelles in mammalian cells, yet
little is known about the exact mechanisms that regulate their pH
and how acidity increases along the endocytic pathway. Although
the V-ATPase is the main contributor to this acidity, how its activity
Figure 4. Effects of U18666A treatment on the pH of late
endosomal lumen (FITC-dextran). FITC-dextran was internalized for
15 minutes and chased for 40 minutes at 37uC in control cells (A, B, C)
and cells treated by U18666A (D, E, F) to allow it to reach late
endosomes. Typical examples of the respective labels are shown (B and
E). The pH of individual organelles was measured by fluorescence ratio
imaging of internalized FITC-Dextran. Pseudocolor pH scale is on the
side. The histograms show the pH distribution of 3346 and 3880
endosomes for the upper and the lower panels, respectively, with the
mean6SD given in the left panels (A and D). The observed difference is
significant according to a paired t-test with p,0.001. Cells were
checked for their phenotype of cholesterol accumulation with filipin
staining (C and F). Bars, 10 mm.
doi:10.1371/journal.pone.0002758.g004
Figure 5. Increase of V1 association to membrane upon
U18666A treatment. PNS was submitted to high speed spinning
and pellet (P) and supernatant (SN) were loaded on a gel. Western
blotting was revealed with V0d and V1E subunit antibody. Quantifica-
tion reveals that upon U18666A treatment, V1E is 4-fold more
associated with the membrane (pellet) than in control cells.
doi:10.1371/journal.pone.0002758.g005
Figure 6. Increased assembly of the two sectors of the V-
ATPase in late endosome. Subcellular fractionation of postnuclear
supernatants (PNS) was performed to separate early (EE) from late
endosomes (LE) and heavy membranes (HM) A: 20 mg of protein from
each fraction were separated in 12.5% SDS-PAGE and blotted for the
presence of TfR (early endosomal marker), V0d and V1B. B: The late
endosomal lipid LBPA was used to follow the distribution of late
endosomes on the gradient. An equal amount of protein was used for
LBPA detection by ELISA with the LBPA antibody (6C4). C: Western blot
was quantified using a Phosphoimager (Bio-Rad Laboratories) and the
ratio V1/V0 was plotted. Note that the ratio LE/EE is higher for the V1B
subunit than for the V0d subunit suggesting a higher assembly of the
V-ATPase in the late endosomes compared to early endosomes.
doi:10.1371/journal.pone.0002758.g006
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is regulated is to a large extent unknown. The main mechanism
described to date is the reversible dissociation of the V0 and V1
domains of the V-ATPase. It was first discovered in yeasts and
insects. In these organisms however, dissociation appears as a
survival mechanism to conserve the ATP stock upon conditions of
energy limitation by glucose deprivation or starvation [7,14,15].
The known glucose-induced signaling pathways do not seem to be
involved since mutants in the ras-cyclic AMP pathway or in the
protein kinase C pathway, continue to assemble in the presence of
glucose [7,61]. Regulation by reversible dissociation has also been
described in specialized mammalian cells, such as renal epithelial
cells, where reversible dissociation is, as in yeast, coupled to glucose
levels [62,63]. The only situation in which changes in V1-V0
association were aimed at controlling endosomal pH was during
maturation of dendritic cells, where increased acidification was
shown to increase the activity of hydrolytic enzymes and thus the
efficiency of antigen processing [16]. Our work suggests that, as in
maturing dendritic cells, increased assembly of the V-ATPase
sectors along the endocytic pathway of fibroblast-like cells
contributes to increasing the acidity of the organelles.
Changes in V1-V0 association raise the questions of the
mechanisms that regulate this process. Our striking finding that
all the subunits of the V-ATPase localized to the DRM fraction and
that treatment of cells with U18666A, which affects late endosomal
cholesterol levels, lead to an increase in V1-V0 association, together
point to a role of the membrane composition in controlling the rate
of V1-V0 association-dissociation. This could be either through the
direct effect of specific lipids on the V-ATPase mediated by a lipid-
protein interaction, or/and through an effect of the membrane
fluidity. High fluidity, as possibly found at the plasma membrane,
would lead to V1 dissociation and a drop in V-ATPase mediated
acidification. Similarly low membrane fluidity, as promoted by
U18666A dependent cholesterol accumulation, would lead to a too
strong V1-V0 interaction preventing proper function of the proton
pump, and thus again reduction in activity. The effect of U18666A
is reminiscent of the marine-derived V-ATPase inhibitor salicyli-
halamide A. This metabolite binds to the Vo complex, as do
Bafilomycin A or concanamycin, but to a different site. More
strikingly, salicylihalamide A triggers a dramatic redistribution of
the V1 complex from the cytoplasm to the endosomes, a
redistribution not observed with the other inhibitors [64]. The
paradoxical effects of U18666A and salicylihalamide A suggest that
excessive stabilization of the V1-V0 complexes is detrimental to the
pumps activity.
The hypothesis that raft-like domains are involved in regulating
the activity of the mammalian V-ATPase is further supported by
findings by others, in yeast, that sphingomyelin [20], and possibly
ceramide [65] modulate the function of the V-ATPase. Interest-
ingly, ceramide was also found to be required for oligomerization
of the plasma membrane proton ATPase in yeast [66].
We wish to mention that the V-ATPase has previously been
found in a raft fraction of the plasma membrane of neurons [67].
However only components of the V0 domain were identified. In
contrast, we here found all eight V1 subunits (table 1). Yoshinaka
et al. [43] hypothesize that the V-ATPase may disassemble during
sample preparation or that the V0 sector selectively associates with
rafts. Our results show that both V1 and V0 sectors can be
recovered in the DRM fraction. The apparent discrepancy
between the two studies could be due to the fact that plasma
membrane fractions were analyzed in the first study and that the
V-ATPase is mostly disassembled at that cellular site as opposed to
endosomes studied here. This interpretation is supported by our
finding that assembly of V1 and V0 increases along the endocytic
pathway and would thus be lowest at the cell surface.
The here identified effect of membrane composition on the
activity of the V-ATPase suggests that diseases that affect lipid
distribution or composition, in particular in the endocytic
pathway, may lead to alterations in endosomal pH. It will
therefore be of interest to determine if endosomal pH is affected in
cells from patients suffering from lipid storage diseases such as
Niemann Pick type C and how this affects endosomal function.
Materials and Methods
Cell, reagents and drug treatment
Monolayers of Baby hamster kidney (BHK) cells were grown
and maintained as described previously [68,69]. The monoclonal
antibodies against LBPA (6C4) and Lamp 1 (4A1) have been
described [58,70]. Monoclonal anti-transferrin receptor antibodies
were from Zymed Laboratories Inc. Rabbit polyclonal anti-flotillin
antibodies were produced by our laboratory [25]. Polyclonal
antibody against the 39-kDa subunit of the V-ATPase (V0d) was
previously described [71]. Rabbit polyclonal antibodies against V1
subunit A and V1 subunit E were kind gifts from I. Schultz and
antibodies against V1 subunit B were produced by Eurogentech.
Rhodamine-dextran (10,000 Da) was from Molecular Probes. For
pH measurement, Lamp1 antibody was labeled with FITC (Fluo
reporter labeling kit) from Molecular probes. Cells were treated
with 3beta-(2-diethylaminoethoxy)-androsterone HCl (U18666A)
as described [34]. Briefly, the cell culture medium was removed
4 hours after plating and fresh medium containing U18666A at
3 mg/ml was added for 18 hours.
Subcellular fractionation and Immunoblotting
Early and late endosomal fractions were prepared as described
[32,34]. Briefly, BHK cells were homogenized, a post nuclear
supernatant (PNS) was prepared, adjusted to 40.6% sucrose,
loaded on the bottom of a SW41 tube and overlaid sequentially
with 35%, 25% and 8.5% sucrose solution in 3mM imidazole,
pH 7.4. The gradient was centrifuged for 90 minutes at
35000 rpm. Heavy membranes, early and late endosomal
fractions were collected at the 40.6/35%, 35/25% and 25/8.5%
interfaces respectively. Proteins were separated by SDS-PAGE
using 12.5% acrylamide gels and transferred onto a nitrocellulose
membrane. Western blots were revealed with SuperSignal
Chemiluminescence (Pierce) and quantified by densitometry.
Isolation of DRMs from early and late endosomal fraction
DRMs were prepared from late endosomes as described [25].
Early or late endosomes were diluted four times, sedimented by
centrifugation (TLS55 Beckman Rotor, 30 min, 55000 rpm) and
resuspended in 200 ml of lysis buffer (25 mM Tris-HCl pH 7.4,
150 mM NaCl, 5 mM EDTA) in the presence of Complete, a
cocktail of protease inhibitors (Roche) and 1% Triton X-100. After
20 min of incubation at 4uC, the lysat was adjusted to 40%OptiPrep
(Nycodenz), overlaid with 30% and 0% OptiPrep cushions and
centrifuged for two hours at 55000 rpm (4uC) using a TSL55 rotor.
Six fractions were collected and precipitated with 6% trichloroacetic
acid in the presence of sodium deoxycholate as a carrier.
Sample preparation for mass spectrometry analysis
DRMs and DSMs fractions were prepared from late endosomes
(200 mg) as explained in precedent paragraph. 30 mg proteins from
recovered DRMs and DSMs fractions were precipitated using
methanol/chloroform. Proteins were then run on 2 cm in one-
dimensional SDS-PAGE (15% acrylamide gel, 0.75 mm thick).
Protein bands (12, and 14 for DRMs and soluble fraction,
respectively) were excised and destained by repeated cycles of
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incubation in 25mM NH4HCO3 for 15 min and then with 50%
(v/v) ACN in the same buffer (25mM NH4HCO3) for 15 min.
After drying by vacuum centrifugation, the gel pieces were
incubated with an oxidizing solution (7% H2O2) for 15 min [72].
Gel pieces were then washed in HPLC grade water (Sigma-
Aldrich) for 15 min before being dehydrated with 100% ACN. In-
gel digestion was performed (0.5 mg trypsin/band; sequencing
grade modified trypsin, Promega) in 25mM NH4HCO3 overnight
at 37uC. Peptides were extracted from the gel using passive
diffusion in the following solutions: 50% ACN, then 5% formic
acid, and finally 100% ACN. The extracts were dried by vacuum
centrifugation and peptides were resolubilized in 5% ACN, 0.2%
formic acid.
MS/MS analysis
The different sample fractions were injected into a CapLC
nanoLC system (Waters) and first preconcentrated on a
300 mm65 mm precolumn (PepMap C18; Dionex). The peptides
were then eluted onto a C18 column (75 mm6150 mm; Dionex).
Chromatographic separation used a gradient transition from
solution A (2% acetonitrile, 98% water and 0.1% formic acid) to
solution B (80% acetonitrile, 20% water and 0.08% formic acid)
over 60 min at a flow rate of 200 nl/min. The LC system was
directly coupled to a mass spectrometer (QTOF; Waters). MS and
MS/MS data were acquired and processed automatically using
MassLynx software (Waters). Database searching was performed
using MASCOT 2.2 software (Matrix Science) using SwissProt_
Trembl as the database and Rodent as the taxonomy. Variable
modifications accorded were: Acetyl N-terminal of protein, simple
and dioxidation of Methionine and cysteic acid on cysteine.
Precisions on both MS and MS/MS data were set to 0.3 Da. The
.dat files obtained through Mascot were further filtered using an
‘‘in-house’’ parsing solution (Irma, to be published: Bioinformatics
Application Notes) build from Mascot Parser. The two sets of data
were checked for false positive but none were found. Peptides
whose score were .= to query identity threshold (p,0.05) and
rank ,=1 were marked as significant through a first filtering and
at final, a manual validation was done on proteins containing only
one or two peptides. The peptide sequences were considered as
validated if they contained at least 3 consecutives Y or B ions with
a S/N threshold .3. Classical MS contaminants such as trypsin
and keratin proteins were removed manually.
Fluorescence microscopy
Cells grown on cover slips were fixed with 3% paraformalde-
hyde for 20 min at room temperature and saturated with 10%
phosphate-buffered saline-fetal calf serum (PBS-FCS) for 20 min.
Cholesterol was labeled with 50 mg/ml Filipin in 10% PBS-FCS.
pH measurements
BHK cells grown on glass cover slips, were incubated with a
FITC conjugated Lamp1 antibody overnight at 37uC or a FITC
dextran for 15 minutes at 37uC and washed for 40 minutes. Late
endosomal pH was measured by ratio fluorescence imaging as
described [73,74] with the use of a Nipkow dual spinning disk
confocal laser imaging system with a QLC module (Visitron
systems GmbH, Switzerland). Cover slips were inserted into a
perfusion chamber (Medical Systems, Green- vale, NY) at 37uC in
1 ml of IM medium and imaged with a video/CCD camera
controlled by MetaMorph/Metafluor imaging software. Images
were acquired for 500 ms at two different wavelengths, using the
two lasers 490 and 440 nm. Calibration and image processing
were performed as described previously [73]. Data were graphed
using the Prism software.
Supporting Information
Figure S1 Effects of b2MCD treatment on the pH of late
endosomal lumen (FITC-dextran). FITC-dextran was internalized
for 15 minutes and chased for 40 minutes at 37uC in control cells
(A) and cells treated by b2MCD (B) to allow it to reach late
endosomes. The histograms show the pH distribution of 3700 and
2194 endosomes for the upper and the lower panels. Values
represent the mean6SD. The observed difference is significant
according to a paired t-test with p,0.001.
Found at: doi:10.1371/journal.pone.0002758.s001 (1.24 MB TIF)
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